Hussam H. Baghdadi
Medina, 42353, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Genetic Studies on Multiple Consanguineous Families Segregating Diverse Phenotypes of Microphthalmia Identified Novel and Recurrent Mutations.
Journal: Current medicinal chemistry
Published: November 10, 2024
Aleppo galls alleviate paracetamol-induced hepatotoxicity and tissue damage: an experimental study.
Journal: International journal of biochemistry and molecular biology
Published: March 28, 2022
Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial.
Journal: American journal of blood research
Published: March 20, 2022
Acute paracetamol toxicity-induced inflammatory and oxidative effects are relieved by Aleppo galls: a novel experimental study.
Journal: International journal of physiology, pathophysiology and pharmacology
Published: March 09, 2022
The Preventive and Therapeutic Effects of Ajwa Date Fruit Extract Against Acute Diclofenac Toxicity-Induced Colopathy: An Experimental Study.
Journal: Drug design, development and therapy
Published: October 13, 2021
Zamzam water is pathogen-free, uricosuric, hypolipidemic and exerts tissue-protective effects: relieving BBC concerns.
Journal: American journal of blood research
Published: June 28, 2020
TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.
Journal: American journal of blood research
Published: May 16, 2020
Al-hijamah (wet cupping therapy of prophetic medicine) significantly and safely reduces iron overload and oxidative stress in thalassemic children: a novel pilot study.
Journal: Journal of blood medicine
Published: December 28, 2018
Dichloroacetate is an antimetabolite that antagonizes acetate and deprives cancer cells from its benefits: A novel evidence-based medical hypothesis.
Journal: Medical hypotheses
Published: July 18, 2018
Targeting Cancer Cells using 3-bromopyruvate for Selective Cancer Treatment.
Journal: Saudi journal of medicine & medical sciences
Published: January 01, 2017
The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view.
Journal: Medical hypotheses
Published: July 11, 2016
Last Updated: 09/26/2026